The tick-over theory revisited: Formation and regulation of the soluble alternative complement C3 convertase (C3(H2O)Bb)

Molecular Immunology

Volumn 45, Issue 8, 2008, Pages 2370-2379

  Bexborn, Fredrik ^a   Andersson, Per Ola ^b   Chen, Hui ^c   Nilsson, Bo ^d   Ekdahl, Kristina N ^a,d  

^a LINNAEUS UNIVERSITY   (Sweden)

^b SWEDISH DEFENCE RESEARCH AGENCY   (Sweden)

^c UNIVERSITY OF PENNSYLVANIA   (United States)

^d UPPSALA UNIVERSITY   (Sweden)

Author keywords

Alternative pathway convertase; C3(H2O); C3b; Factor B; Fluid phase; Fluorescence resonance energy transfer (FRET)

Indexed keywords

ALTERNATIVE COMPLEMENT PATHWAY C3 C5 CONVERTASE; COMPLEMENT FACTOR H; FIBRINOGEN;

ARTICLE; ENZYME ACTIVITY; ENZYME LINKED IMMUNOSORBENT ASSAY; FLUORESCENCE RESONANCE ENERGY TRANSFER; PRIORITY JOURNAL; WESTERN BLOTTING;

BLOTTING, WESTERN; COMPLEMENT C3 CONVERTASE, ALTERNATIVE PATHWAY; COMPLEMENT C3-C5 CONVERTASES; COMPLEMENT C3B; COMPLEMENT FACTOR B; COMPLEMENT FACTOR H; COMPLEMENT FACTOR I; ELECTROPHORESIS, POLYACRYLAMIDE GEL; ENZYME-LINKED IMMUNOSORBENT ASSAY; FLUORESCENCE RESONANCE ENERGY TRANSFER; HUMANS; HYDROLYSIS; INDICATORS AND REAGENTS; MODELS, IMMUNOLOGICAL; MOLECULAR WEIGHT; SOLUBILITY; SOLUTIONS; SPECTRUM ANALYSIS; TIME FACTORS;

IXODIDA;

EID: 40149093101     PISSN: 01615890     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.molimm.2007.11.003     Document Type: Article

References (41)

1. Andersson, J., Ekdahl, K.N., Lambris, J.D., Nilsson, B., 2005. Binding of C3 fragments on top of adsorbed plasma proteins during complement activation on a model biomaterial surface. Biomaterials 26, 1477-1485.
2. Andersson, J., Ekdahl, K.N., Larsson, R., Nilsson, U.R., Nilsson, B., 2002. C3 adsorbed to a polymer surface can form an initiating alternative pathway convertase. J. Immunol. 168, 5786-5791.
3. Asghar, S.S., Barendsen, C.Y., van der Helm, H.J., 1987. Reinvestigations into the formation and assay of C3bBbP complexes. Clin. Chim. Acta 165, 243-252.
4. Bokisch, V.A., Dierich, M.P., Müller-Eberhard, H.J., 1975. Third component of complement (C3): structural properties in relation to functions. Proc. Natl. Acad. Sci. U.S.A. 72, 1989-1993.
5. Catana, E., Schifferli, J.A., 1991. Purification of human complement factor D from the peritoneal fluid of patients on chronic ambulatory peritoneal dialysis. J. Immunol. Methods 138, 265-271.
6. Ekdahl, K.N., Nilsson, B., Pekna, M., Nilsson, U.R., 1992. Generation of iC3 at the interface between blood and gas. Scand. J. Immunol. 35, 85-91.
7. Fearon, D.T., 1977. Purification of C3b inactivator and demonstration of its two polypeptide chain structure. J. Immunol. 119, 1248-1252.
8. Fearon, D.T., Austen, K.F., 1975a. Properdin: binding to C3b and stabilization of the C3b-dependent C3 convertase. J. Exp. Med. 142, 856-863.
9. Fearon, D.T., Austen, K.F., 1975b. Properdin: initiation of alternative complement pathway. Proc. Natl. Acad. Sci. U.S.A. 72, 3220-3224.
10. Fearon, D.T., Austen, K.F., Ruddy, S., 1973. Formation of a hemolytically active cellular intermediate by the interaction between properdin factors B and D and the activated third component of complement. J. Exp. Med. 138, 1305-1313.
11. Fishelson, Z., Pangburn, M.K., Müller-Eberhard, H.J., 1983. C3 convertase of the alternative complement pathway. Demonstration of an active, stable C3b, Bb (Ni) complex. J. Biol. Chem. 258, 7411-7415.
12. Fishelson, Z., Pangburn, M.K.,Müller-Eberhard, H.J., 1984. Characterization of the initial C3 convertase of the alternative pathway of human complement. J. Immunol. 132, 1430-1434.
13. Hammer, C.H.,Wirtz, G.H., Renfer, L., Gresham, H.D., Tack, B.F., 1981. Large scale isolation of functionally active components of the human complement system. J. Biol. Chem. 256, 3995-4006.
14. Hinshelwood, J., Perkins, S.J., 2000. Conformational changes during the assembly of factor B from its domains by (1)H NMR spectroscopy and molecular modelling: their relevance to the regulation of factor B activity. J.Mol. Biol. 301, 1267-1285.
15. Hourcade, D.E., Wagner, L.M., Oglesby, T.J., 1995. Analysis of the short consensus repeats of human complement factor B by site-directed mutagenesis. J. Biol. Chem. 270, 19716-19722.
16. Isenman, D.E., Kells, D.I., Cooper, N.R., Müller-Eberhard, H.J., Pangburn, M.K., 1981. Nucleophilic modification of human complement protein C3: correlation of conformational changes with acquisition of C3b-like functional properties. Biochemistry 20, 4458-4467.
17. Janssen, B.J., Christodoulidou, A., McCarthy, A., Lambris, J.D., Gros, P., 2006. Structure of C3b reveals conformational changes that underlie complement activity. Nature 444, 213-216.
18. Janssen, B.J., Huizinga, E.G., Raaijmakers, H.C., Roos, A., Daha, M.R., Ekdahl, K.N., Nilsson, B., Gros, P., 2005. Structures of complement component C3 provide insights into the function and evolution of immunity. Nature 437, 505-511.
19. Jokiranta, T.S., Westin, J., Nilsson, U.R., Nilsson, B., Hellwage, J., Lofas, S., Gordon, D.L., Ekdahl, K.N., Meri, S., 2001. Complement C3b interactions studied with surface plasmon resonance technique. Int. Immunopharmacol. 1, 495-506.
20. Lachmann, P.J., Halbwachs, L., 1975. The influence of C3b inactivator (KAF) concentration on the ability of serum to support complement activation. Clin. Exp. Immunol. 21, 109-114.
21. Lambris, J.D., Müller-Eberhard, H.J., 1984. Isolation and characterization of a 33,000-dalton fragment of complement factor B with catalytic and C3b binding activity. J. Biol. Chem. 259, 12685-12690.
22. Law, S.K., Levine, R.P., 1977. Interaction between the third complement protein and cell surface macromolecules. Proc. Natl. Acad. Sci. U.S.A. 74, 2701-2705.
23. Lichlyter, D.J., Grant, S.A., Soykan, O., 2003. Development of a novel FRET immunosensor technique. Biosens. Bioelectron. 19, 219-226.
24. Milder, F.J., Gomes, L., Schouten, A., Janssen, B.J., Huizinga, E.G., Romijn, R.A., Hemrika,W., Roos, A., Daha, M.R., Gros, P., 2007. Factor B structure provides insights into activation of the central protease of the complement system. Nat. Struct. Mol. Biol. 14, 224-228.
25. Müller-Eberhard, H.J., Schreiber, R.D., 1980. Molecular biology and chemistry of the alternative pathway of complement. Adv. Immunol. 29, 1-53.
26. Nilsson, B., Svensson, K.E., Inganas, M., Nilsson, U.R., 1988. A simplified assay for the detection of C3a in human plasma employing a monoclonal antibody raised against denatured C3. J. Immunol. Methods 107, 281-287.
27. Nilsson, U.R., Larm, O., Nilsson, B., Storm, K.E., Elwing, H., Ekdahl, K.N., 1993. Modification of the complement binding properties of polystyrene: effects of end-point heparin attachment. Scand. J. Immunol. 37, 349-354.
28. Nilsson, U.R., Müller-Eberhard, H.J., 1965. Isolation of beta If-globulin from human serum and its characterization as the fifth component of complement. J. Exp. Med. 122, 277-298.
29. Nishida, N.,Walz, T., Springer, T.A., 2006. Structural transitions of complement component C3 and its activation products. Proc. Natl. Acad. Sci. U.S.A. 103, 19737-19742.
30. Pangburn, M.K., 1987. A fluorimetric assay for native C3. The hemolytically active form of the third component of human complement. J. Immunol. Methods 102, 7-14.
31. Pangburn, M.K.,Müller-Eberhard, H.J., 1986. The C3 convertase of the alternative pathway of human complement. Enzymic properties of the bimolecular proteinase. Biochem. J. 235, 723-730.
32. Pangburn, M.K., Müller-Eberhard, H.J., 1983. Initiation of the alternative complement pathway due to spontaneous hydrolysis of the thioester of C3. Ann. N Y. Acad. Sci. 421, 291-298.
33. Pangburn, M.K., Schreiber, R.D.,Müller-Eberhard, H.J., 1977. Human complement C3b inactivator: isolation, characterization, and demonstration of an absolute requirement for the serum protein beta1H for cleavage of C3b and C4b in solution. J. Exp. Med. 146, 257-270.
34. Pangburn, M.K., Schreiber, R.D.,Müller-Eberhard, H.J., 1981. Formation of the initial C3 convertase of the alternative complement pathway. Acquisition of C3b-like activities by spontaneous hydrolysis of the putative thioester in native C3. J. Exp. Med. 154, 856-867.
35. Pekna, M., Nilsson, L., Ekdahl, K.N., Nilsson, U.R., Nilsson, B., 1993. Evidence for iC3 generation during cardiopulmonary bypass as the result of blood-gas interaction. Clin. Exp. Immunol. 91, 404-409.
36. Pryzdial, E.L., Isenman, D.E., 1987. Alternative complement pathway activation fragment Ba binds to C3b. Evidence that formation of the factor B-C3b complex involves two discrete points of contact. J. Biol. Chem. 262, 1519-1525.
37. Pryzdial, E.L., Isenman, D.E., 1988. A thermodynamic study of the interaction between human complement components C3b or C3(H2O) and factor B in solution. J. Biol. Chem. 263, 1733-1738.
38. Schwaeble, W.J., Reid, K.B., 1999. Does properdin crosslink the cellular and the humoral immune response? Immunol. Today 20, 17-21.
39. Smith, C.A.,Vogel, C.W.,Müller-Eberhard, H.J., 1984.MHCClass III products: an electron microscopic study of the C3 convertases of human complement. J. Exp. Med. 159, 324-329.
40. Ueda, A., Kearney, J.F., Roux, K.H., Volanakis, J.E., 1987. Probing functional sites on complement protein B with monoclonal antibodies. Evidence for C3b-binding sites on Ba. J. Immunol. 138, 1143-1149.
41. Vogt,W., Dames,W., Schmidt, G., Dieminger, L., 1977. Complement activation by the properdin system: formation of a stoichiometric. C3 cleaving complex of properdin factor B with C36. Immunochemistry 14, 201-205.